Navigation Links
Gen-Probe to Webcast Presentations at Lehman and Cowen Healthcare Conferences
Date:3/12/2008

SAN DIEGO, March 12 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the Company will present at the Lehman Brothers 11th Annual Global Healthcare Conference in Miami Beach on March 18, 2008 at approximately 3:15 p.m. Eastern Time, and at the Cowen and Company 28th Annual Healthcare Conference in Boston on March 19, 2008 at approximately 8:00 a.m. Eastern Time. Both presentations are scheduled to be webcast live and may be accessed through a link on the investors section of Gen-Probe's website at http://www.gen-probe.com. The webcasts will be available for 30 days following the events.

About Gen-Probe

Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. Gen-Probe has approximately 25 years of NAT expertise, and received the 2004 National Medal of Technology, America's highest honor for technological innovation, for developing NAT assays for blood screening. Gen-Probe is headquartered in San Diego and employs approximately 1,000 people. For more information, go to http://www.gen-probe.com.

Caution Regarding Forward-Looking Statements

Any statements in this press release about our expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to differ materially from those expressed or implied by any forward-looking statement. For information about risks and uncertainties we face and a discussion of our financial statements and footnotes, see documents we have filed with the SEC, including the Form 10-K for the year ended December 31, 2007, and all subsequent periodic filings made with the SEC. We assume no obligation and expressly disclaim any duty to update any forward-looking statement to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events.

Contact:

Paula Izidoro

Investor Relations

858-410-8904


'/>"/>
SOURCE Gen-Probe Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007
2. Carl Hull Named President and Chief Operating Officer of Gen-Probe
3. Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2007 Earnings Conference Call
4. Gen-Probe to Webcast Three Upcoming Presentations
5. Gen-Probe Reports Strong Financial Results for Third Quarter 2007, Raises Full-Year Guidance for Earnings Per Share and Total Revenues
6. Gen-Probe to Webcast Presentation at Bank of Americas 37th Annual Investment Conference
7. Exelixis Announces March 17 Webcast of Presentation at the Cowen and Company Annual Health Care Conference
8. Volcano Corporation Presentation at Cowen Healthcare Conference to be Webcast
9. MIGENIX Third Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification
10. Wyeth Sets Webcast And Conference Call For 2008 First Quarter Earnings
11. Oncothyreon announces March 10th webcast of fourth quarter and full year financial results conference call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/11/2017)... , ... January 11, 2017 , ... ... are observed in clinical settings, it is becoming increasingly clear that the evolution ... on culture-based methods, the standard in the study of clinical resistance, has vastly ...
(Date:1/11/2017)... ... January 11, 2017 , ... IsoPlexis Corporation ... platform to measure the proteomic function of individual cells in patients, today announced ... grant from the National Institute on Aging of the National Institutes of Health ...
(Date:1/11/2017)... Collins, Colorado (PRWEB) , ... January 11, 2017 ... ... of dynamic aqueous plasma technology platforms, announced today that the National Science Foundation ... IIB supplement for $500,000. The funds will be used to commercialize the Symbios ...
(Date:1/11/2017)... ... January 11, 2017 , ... Advanced Polymer Monitoring Technologies (APMT) ... Bartylla will lead European initiatives for APMT’s product lines serving polymer and biopharmaceutical ... to European manufacturers and researchers. Bernhard brings significant experience in our application areas ...
Breaking Biology Technology:
(Date:1/4/2017)... , Jan. 4, 2017  For the thousands of attendees at ... global leader in connected health and biometric measurement devices and services, will ... On display in A&D Medical,s special CES Exhibit Suite ... the ongoing expansion of the company,s WellnessConnected product platform.  ... ...
(Date:12/22/2016)... , Dec. 20, 2016  As part of its longstanding ... leading personal genetics company, recently released its latest children,s book, ... The book focuses on the topics of inheritance and variation ... Standards (NGSS) taught in elementary school classrooms in the US. ... series by illustrator Ariana Killoran , whose previous book ...
(Date:12/20/2016)... Dec, 20, 2016   Valencell , the ... and STMicroelectronics (NYSE: STM), a global semiconductor ... applications, announced today the launch of a new, ... wearables that includes ST,s compact SensorTile ... biometric sensor system. Together, SensorTile and Benchmark ...
Breaking Biology News(10 mins):